E-LIB Suche - Ergebnisse für: Kodali, Revathi

1

MIDD0301 – A first‐in‐class anti‐inflammatory asthma drug t..:

Zahn, Nicolas M. ; Huber, Alec T. ; Mikulsky, Brandon N....
Basic & Clinical Pharmacology & Toxicology. 125 (2019) 1 - p. 75-84 , 2019

Link: https://doi.org/10.1111/..

2

Correction to "A Novel Orally Available Asthma Drug Candida..:

Forkuo, Gloria S. ; Nieman, Amanda N. ; Kodali, Revathi...
Molecular Pharmaceutics. 16 (2019) 11 - p. 4756-4756 , 2019

Link: https://doi.org/10.1021/..

3

T117. Pro-Cognitive Properties of a Novel GABA-A Receptor P..:

Prevot, Thomas ; Li, Guanguan ; Misquitta, Keith...
Biological Psychiatry. 85 (2019) 10 - p. S174 , 2019

Link: https://doi.org/10.1016/..

4

Design and Evaluation of Heterobivalent PAR1–PAR2 Ligands a..:

Majewski, Mark W. ; Gandhi, Disha M. ; Rosas Jr., Ricardo...
ACS Medicinal Chemistry Letters. 10 (2018) 1 - p. 121-126 , 2018

Link: https://doi.org/10.1021/..

5

Clinical Drug Candidate MIDD0301 is a Novel Oral Asthma Tre..:

Arnold, Leggy A. ; Forkuo, Gloria ; Nieman, Amanda...
Journal of Allergy and Clinical Immunology. 141 (2018) 2 - p. AB81 , 2018

Link: https://doi.org/10.1016/..

6

Design and Synthesis of Novel Deuterated Ligands Functional..:

Knutson, Daniel E. ; Kodali, Revathi ; Divović, Branka...
Journal of Medicinal Chemistry. 61 (2018) 6 - p. 2422-2446 , 2018

Link: https://doi.org/10.1021/..

7

A Novel Orally Available Asthma Drug Candidate That Reduces..:

Forkuo, Gloria S. ; Nieman, Amanda N. ; Kodali, Revathi...
Molecular Pharmaceutics. 15 (2018) 5 - p. 1766-1777 , 2018

Link: https://doi.org/10.1021/..

8

Attaining in vivo selectivity of positive modulation of α3β..:

Batinić, Bojan ; Stanković, Tamara ; Stephen, Michael Rajesh...
European Neuropsychopharmacology. 28 (2018) 8 - p. 903-914 , 2018

Link: https://doi.org/10.1016/..

9

Alleviation of Multiple Asthmatic Pathologic Features with ..:

Forkuo, Gloria S. ; Nieman, Amanda N. ; Yuan, Nina Y....
Molecular Pharmaceutics. 14 (2017) 6 - p. 2088-2098 , 2017

Link: https://doi.org/10.1021/..

10

Pharmacological and antihyperalgesic properties of the nove..:

Fischer, Bradford D. ; Schlitt, Raymond J. ; Hamade, Bryan Z....
Brain Research Bulletin. 131 (2017) - p. 62-69 , 2017

Link: https://doi.org/10.1016/..

11

New Oral Treatments for Asthma through Tissue-Specific Modu..:

Arnold, Leggy ; Forkuo, Gloria ; Nieman, Amanda...
Journal of Allergy and Clinical Immunology. 139 (2017) 2 - p. AB9 , 2017

Link: https://doi.org/10.1016/..

12

Optimization of substituted imidazobenzodiazepines as novel..:

Jahan, Rajwana ; Stephen, Michael Rajesh ; Forkuo, Gloria S....
European Journal of Medicinal Chemistry. 126 (2017) - p. 550-560 , 2017

Link: https://doi.org/10.1016/..

13

α4‐selective GABAA Receptor Positive Allosteric Modulator A..:

FORKUO, GLORIA ; Nieman, Amanda ; Yu, Olivia...
The FASEB Journal. 30 (2016) S1 - p. , 2016

Link: https://doi.org/10.1096/..

14

A New Pharmacological Approach for Asthma through Tissue-Sp..:

Arnold, Leggy A. ; Forkuo, Gloria S. ; Nieman, Amanda N....
Journal of Allergy and Clinical Immunology. 137 (2016) 2 - p. AB393 , 2016

Link: https://doi.org/10.1016/..

15

Development of GABAA Receptor Subtype-Selective Imidazobenz..:

Forkuo, Gloria S. ; Guthrie, Margaret L. ; Yuan, Nina Y....
Molecular Pharmaceutics. 13 (2016) 6 - p. 2026-2038 , 2016

Link: https://doi.org/10.1021/..